These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9828102)

  • 21. Rat cortical neuron cultures: an in vitro model for differentiating mechanisms of chemically induced neurotoxicity.
    Schmuck G; Ahr HJ; Schlüter G
    In Vitr Mol Toxicol; 2000; 13(1):37-50. PubMed ID: 10900406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW; Goldenberg S; Pastan I; Gottesman MM
    J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue.
    McNeil RS; Swann JW; Brinkley BR; Clark GD
    Cell Motil Cytoskeleton; 1999; 43(2):99-113. PubMed ID: 10379835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells.
    Zisowsky J; Koegel S; Leyers S; Devarakonda K; Kassack MU; Osmak M; Jaehde U
    Biochem Pharmacol; 2007 Jan; 73(2):298-307. PubMed ID: 17097621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
    Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
    Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate filament cytoskeletal system: dynamic and mechanical properties.
    Goldman RD; Clement S; Khuon S; Moir R; Trejo-Skalli A; Spann T; Yoon M
    Biol Bull; 1998 Jun; 194(3):361-2; discussion 362-3. PubMed ID: 9664663
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity.
    Liu L; Yang C; Herzog C; Seth R; Kaushal GP
    Biochem Pharmacol; 2010 Jan; 79(2):137-46. PubMed ID: 19699182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoskeleton and vesicle mobility in astrocytes.
    Potokar M; Kreft M; Li L; Daniel Andersson J; Pangrsic T; Chowdhury HH; Pekny M; Zorec R
    Traffic; 2007 Jan; 8(1):12-20. PubMed ID: 17229312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermediate filaments as signaling platforms.
    Pallari HM; Eriksson JE
    Sci STKE; 2006 Dec; 2006(366):pe53. PubMed ID: 17179489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury.
    Jung M; Hotter G; Viñas JL; Sola A
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):236-46. PubMed ID: 19038279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of Rho kinase in reorganization of the vascular endothelial cytoskeleton induced by rat burn serum].
    Zheng HZ; Zhao KS; Huang QB
    Zhonghua Shao Shang Za Zhi; 2005 Jun; 21(3):181-4. PubMed ID: 15996278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade.
    Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K
    Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines.
    Shen DW; Liang XJ; Gawinowicz MA; Gottesman MM
    Mol Pharmacol; 2004 Oct; 66(4):789-93. PubMed ID: 15385639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of protein phosphatase 2A with its substrate vimentin intermediate filaments in 9L rat brain tumor cells.
    Cheng TJ; Lin YL; Chiang AS; Lai YK
    J Cell Biochem; 2000 Jul; 79(1):126-38. PubMed ID: 10906761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.